Adrian Sacher

机构：University of Toronto, Princess Margaret Cancer Centre, London Rebuilding Society

发表论文 1 篇

代表论文

• A plain language summary of the SAVANNAH study: savolitinib plus osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer with MET overexpression and/or amplification whose cancer had grown or spread on osimertinib (2026 · Future Oncology)